NASDAQ: EUDA
Euda Health Holdings Ltd Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their EUDA stock forecasts and price targets.

Forecast return on equity

Is EUDA forecast to generate an efficient return?

Insufficient data to display

Forecast return on assets

Is EUDA forecast to generate an efficient return on assets?

Company
N/A
Industry
-4.98%

EUDA earnings per share forecast

What is EUDA's earnings per share in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$0.08
Avg 2 year Forecast
-$0.06

EUDA revenue forecast

What is EUDA's revenue in the next 3 years based on estimates from 1 analyst?

Avg 1 year Forecast
$8.1M+186.97%
Avg 2 year Forecast
$14.4M+412.7%
Avg 3 year Forecast
$23.3M+729.57%
EUDA's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

EUDA revenue growth forecast

How is EUDA forecast to perform vs Health Information Services companies and vs the US market?

Company
133.04%
Industry
7.76%
Market
7.5%
EUDA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
EUDA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

EUDA vs Health Information Service Stocks

TickerPricePrice TargetUp/downsideConsensus
EUDA$4.67N/AN/A
NUTX$38.19$55.00+44.02%Strong Buy
MPLN$6.96$25.00+259.20%Hold
SOPH$3.36$6.50+93.68%Strong Buy
OPRX$5.23$8.80+68.26%Buy

Euda Health Holdings Stock Forecast FAQ

What is EUDA's earnings growth forecast for 2024-2025?

(NASDAQ: EUDA) Euda Health Holdings's forecast annual earnings growth rate of N/A is not forecast to beat the US Health Information Services industry's average forecast earnings growth rate of 12.42%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 19.94%.

Euda Health Holdings's earnings in 2024 is -$18,353,007.On average, 1 Wall Street analyst forecast EUDA's earnings for 2024 to be -$2,859,544, with the lowest EUDA earnings forecast at -$2,859,544, and the highest EUDA earnings forecast at -$2,859,544.

In 2025, EUDA is forecast to generate -$2,144,658 in earnings, with the lowest earnings forecast at -$2,144,658 and the highest earnings forecast at -$2,144,658.

If you're new to stock investing, here's how to buy Euda Health Holdings stock.

What is EUDA's revenue growth forecast for 2024-2026?

(NASDAQ: EUDA) Euda Health Holdings's forecast annual revenue growth rate of 133.04% is forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 7.76%, and it is also forecast to beat the US market's average forecast revenue growth rate of 7.5%.

Euda Health Holdings's revenue in 2024 is $2,808,686.On average, 1 Wall Street analysts forecast EUDA's revenue for 2024 to be $288,099,050, with the lowest EUDA revenue forecast at $288,099,050, and the highest EUDA revenue forecast at $288,099,050. On average, 1 Wall Street analysts forecast EUDA's revenue for 2025 to be $514,717,906, with the lowest EUDA revenue forecast at $514,717,906, and the highest EUDA revenue forecast at $514,717,906.

In 2026, EUDA is forecast to generate $832,842,167 in revenue, with the lowest revenue forecast at $832,842,167 and the highest revenue forecast at $832,842,167.

What is EUDA's forecast return on assets (ROA) for 2024-2026?

(NASDAQ: EUDA) forecast ROA is N/A, which is lower than the forecast US Health Information Services industry average of -4.98%.

What is EUDA's Earnings Per Share (EPS) forecast for 2024-2025?

(NASDAQ: EUDA) Euda Health Holdings's current Earnings Per Share (EPS) is -$0.63. On average, analysts forecast that EUDA's EPS will be -$0.08 for 2024, with the lowest EPS forecast at -$0.08, and the highest EPS forecast at -$0.08. In 2025, EUDA's EPS is forecast to hit -$0.06 (min: -$0.06, max: -$0.06).

What is EUDA's forecast return on equity (ROE) for 2024-2026?

(NASDAQ: EUDA) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.